GlaxoSmithKline Pakistan Market Cap

GlaxoSmithKline Pakistan has a market cap or net worth of 141.55 billion as of April 24, 2025. Its market cap has increased by 426.42% in one year.

Market Cap

141.55B

Enterprise Value

135.40B

Revenue

61.19B

Ranking

n/a

PE Ratio

21.66

Stock Price

444.46

Market Cap Chart

Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 141.55B, an increase of 3,653.69%. That is a compound annual growth rate of 12.58%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	144.99B	14.70%
Dec 31, 2024	126.40B	378.26%
Dec 29, 2023	26.43B	-5.45%
Dec 30, 2022	27.95B	-35.70%
Dec 31, 2021	43.47B	-28.84%
Dec 31, 2020	61.09B	19.47%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abbott Laboratories (Pakistan)	103.77B
AGP Limited	55.48B
Highnoon Laboratories	49.28B
The Searle Company	49.02B
Shifa International Hospitals	27.38B
Citi Pharma	21.76B
Ferozsons Laboratories	13.31B
Otsuka Pakistan	2.08B

Market Cap Rankings